L’approvisionnement en produits pharmaceutiques repose sur une liste de médicaments essentiels afin de réndre les prescriptions plus efficace. 12 oct. Asthénie; Nausées, épigastralgies, aphtes, mucite, diarrhée; Modifications de la peau et des cheveux; Anorexie, dysgueusie; Epistaxis. Cat devant un épistaxis post opératoire. Emmanuel RACY (Paris). CAT devant sténose post traumatique des vl. E. FEVRIER, Jacques LAGIER (NICE).

Author: Brat Sak
Country: Guyana
Language: English (Spanish)
Genre: Software
Published (Last): 28 June 2014
Pages: 174
PDF File Size: 10.35 Mb
ePub File Size: 18.32 Mb
ISBN: 783-4-29404-189-9
Downloads: 34413
Price: Free* [*Free Regsitration Required]
Uploader: Nalmaran

Comment citer ce chapitre?

Epistaxis, étiologies et traitement général | thoracotomie

La classification OMS des TNE digestives ne prenait pas en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1. Chimioembolisation [Zappa ] Contre-indications: Suspicion de tumeur mixte comportant un contingent neuroendocrine.

TNE de sites rares ou inhabituels 2. TNE de primitif inconnu. Somatuline LP 60, 90 et mg: Prise en charge des principaux effets secondaires: Bulletin du Cancer ; 2: Examens morphologiques initiaux Il faut y associer la classification pTNM.

Entre 1 et 2 cm: TNE gastrique sporadique i. Indications du traitement antitumoral non chirurgical: Everolimus quel que soit le volume tumoral niveau de la recommandation: Options Irinotecan-cisplatine [Nakano ] niveau de la recommandation: Ne pas utiliser si: J 15 et J 30 puis tous les mois Clinique: Bilan initial et surveillance: DTIC therapy in patients with malignant intraabdominal neuroendocrine tumors.

Antonodimitrakis P et al. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Are capecitabine and oxaliplatin XELOX suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? The high-grade WHO G3 pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.

Am J Surg Pathol. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. Computed tomography — an increasing source of radiation exposure.

Dig Liver Dis ; Lanreotide in metastatic enteropancreatic neuroendocrine tumors.


post partum haemorrhage: Topics by

N Engl J Med. Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma. Expert Rev Anticancer Ther. Review and Position Statement.

Epiistaxis expression epistaxiz response to temozolomide in pancreatic neuroendocrine tumors. Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with epistaxid alpha for advanced carcinoid tumors: Updating the management of patients with rectal neuroendocrine tumors. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.

Chromosomal alterations and germline inositol polyphosphate multikinase sequencing. The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Clin Cancer Res ; Hepatic metastases from neuroendocrine tumors devqnt a “thin slice” pathological examination: Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors–the International Lanreotide and Interferon Alfa Study Group.

Fazio N, Milione M. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Neuroendocrinology sous presse. WHO classification of neoplasms of the neuroendocrine pancreas. WHO classification of tumours of endocrine organs. O6-methylguanine DNA methyltransferase deficiency and response epjstaxis temozolomide-based therapy in patients with neuroendocrine tumors.

J Clin Oncol ;33 suppl: World J Surg ;37 7: Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from episfaxis midgut endocrine tumors: Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer ; Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

N Engl J Med ; Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects.

J Clin Endocrinol Metab. Analysis of the NCDB. Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.


Mefloquine for preventing malaria during travel to endemic areas

Jpn J Clin Oncol. Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors. Eur J Gastroenterol Hepatol.

The Concept cevant Skip Metastases. Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas. J Interferon Cytokine Res ; Diagnosis and Prognostic Stratification. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Calculation of the Ki67 index in pancreatic neuroendocrine tumors: TNM staging of foregut neuro endocrine tumors: Epkstaxis staging of midgut and hindgut neuro endocrine tumors: Nomenclature and classification of neuroendocrine neoplasms of the digestive system.

WHO classification of tumours of the digestive system. International Angency for Research on Cancer Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in cevant control oftumor growth in patients with metastatic neuroendocrine midgut tumors: Treatment of metastasized midgut carcinoids with dacarbazine.

Am J Gastroenterol ; Histological typing of endocrine tumours. International histological classification of tumours.

First-line chemotherapy with capecitabine and temozolomide in patients with episyaxis pancreatic endocrine carcinomas. Cancer Epistaxiis 15; 2: TNM Classification of malignant tumours. Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: Int J Biol Markers.

O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Everolimus for advanced pancreatic neuroendocrine tumors. Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.

Pour en savoir plus: Intervention in gastro-enteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol.